nodes	percent_of_prediction	percent_of_DWPC	metapath
Apraclonidine—Skin disorder—Cyclosporine—psoriasis	0.000738	0.000738	CcSEcCtD
Apraclonidine—Angiopathy—Betamethasone—psoriasis	0.000736	0.000736	CcSEcCtD
Apraclonidine—Angiopathy—Dexamethasone—psoriasis	0.000736	0.000736	CcSEcCtD
Apraclonidine—Infection—Mycophenolate mofetil—psoriasis	0.000736	0.000736	CcSEcCtD
Apraclonidine—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.000726	0.000726	CcSEcCtD
Apraclonidine—Arrhythmia—Dexamethasone—psoriasis	0.000725	0.000725	CcSEcCtD
Apraclonidine—Arrhythmia—Betamethasone—psoriasis	0.000725	0.000725	CcSEcCtD
Apraclonidine—Ill-defined disorder—Triamcinolone—psoriasis	0.000722	0.000722	CcSEcCtD
Apraclonidine—Skin disorder—Mycophenolate mofetil—psoriasis	0.000719	0.000719	CcSEcCtD
Apraclonidine—Bradycardia—Prednisone—psoriasis	0.000719	0.000719	CcSEcCtD
Apraclonidine—Vomiting—Hydroxyurea—psoriasis	0.000713	0.000713	CcSEcCtD
Apraclonidine—Discomfort—Prednisolone—psoriasis	0.000712	0.000712	CcSEcCtD
Apraclonidine—Abdominal discomfort—Methotrexate—psoriasis	0.000707	0.000707	CcSEcCtD
Apraclonidine—Haemorrhage—Prednisone—psoriasis	0.000707	0.000707	CcSEcCtD
Apraclonidine—Erythema—Betamethasone—psoriasis	0.000706	0.000706	CcSEcCtD
Apraclonidine—Erythema—Dexamethasone—psoriasis	0.000706	0.000706	CcSEcCtD
Apraclonidine—Dermatitis—Hydroxyurea—psoriasis	0.000706	0.000706	CcSEcCtD
Apraclonidine—Myalgia—Hydrocortisone—psoriasis	0.000704	0.000704	CcSEcCtD
Apraclonidine—Malaise—Triamcinolone—psoriasis	0.000702	0.000702	CcSEcCtD
Apraclonidine—Headache—Hydroxyurea—psoriasis	0.000702	0.000702	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.000699	0.000699	CcSEcCtD
Apraclonidine—Syncope—Triamcinolone—psoriasis	0.000698	0.000698	CcSEcCtD
Apraclonidine—Discomfort—Hydrocortisone—psoriasis	0.000696	0.000696	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.000692	0.000692	CcSEcCtD
Apraclonidine—Oedema—Prednisolone—psoriasis	0.000691	0.000691	CcSEcCtD
Apraclonidine—Insomnia—Cyclosporine—psoriasis	0.000687	0.000687	CcSEcCtD
Apraclonidine—Paraesthesia—Cyclosporine—psoriasis	0.000682	0.000682	CcSEcCtD
Apraclonidine—Dyspnoea—Cyclosporine—psoriasis	0.000677	0.000677	CcSEcCtD
Apraclonidine—Somnolence—Cyclosporine—psoriasis	0.000675	0.000675	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.000675	0.000675	CcSEcCtD
Apraclonidine—Oedema—Hydrocortisone—psoriasis	0.000675	0.000675	CcSEcCtD
Apraclonidine—Asthenia—Mycophenolic acid—psoriasis	0.000673	0.000673	CcSEcCtD
Apraclonidine—Infection—Hydrocortisone—psoriasis	0.00067	0.00067	CcSEcCtD
Apraclonidine—Insomnia—Mycophenolate mofetil—psoriasis	0.00067	0.00067	CcSEcCtD
Apraclonidine—Nausea—Hydroxyurea—psoriasis	0.000666	0.000666	CcSEcCtD
Apraclonidine—Paraesthesia—Mycophenolate mofetil—psoriasis	0.000665	0.000665	CcSEcCtD
Apraclonidine—Pruritus—Mycophenolic acid—psoriasis	0.000664	0.000664	CcSEcCtD
Apraclonidine—Myalgia—Triamcinolone—psoriasis	0.000663	0.000663	CcSEcCtD
Apraclonidine—Nervous system disorder—Hydrocortisone—psoriasis	0.000662	0.000662	CcSEcCtD
Apraclonidine—Eye disorder—Prednisone—psoriasis	0.00066	0.00066	CcSEcCtD
Apraclonidine—Dyspnoea—Mycophenolate mofetil—psoriasis	0.00066	0.00066	CcSEcCtD
Apraclonidine—Somnolence—Mycophenolate mofetil—psoriasis	0.000659	0.000659	CcSEcCtD
Apraclonidine—Infestation—Methotrexate—psoriasis	0.000658	0.000658	CcSEcCtD
Apraclonidine—Infestation NOS—Methotrexate—psoriasis	0.000658	0.000658	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000656	0.000656	CcSEcCtD
Apraclonidine—Skin disorder—Hydrocortisone—psoriasis	0.000655	0.000655	CcSEcCtD
Apraclonidine—Ill-defined disorder—Dexamethasone—psoriasis	0.000655	0.000655	CcSEcCtD
Apraclonidine—Ill-defined disorder—Betamethasone—psoriasis	0.000655	0.000655	CcSEcCtD
Apraclonidine—Discomfort—Triamcinolone—psoriasis	0.000655	0.000655	CcSEcCtD
Apraclonidine—Fatigue—Cyclosporine—psoriasis	0.000655	0.000655	CcSEcCtD
Apraclonidine—Pain—Cyclosporine—psoriasis	0.000649	0.000649	CcSEcCtD
Apraclonidine—Constipation—Cyclosporine—psoriasis	0.000649	0.000649	CcSEcCtD
Apraclonidine—Dry mouth—Triamcinolone—psoriasis	0.000648	0.000648	CcSEcCtD
Apraclonidine—Diarrhoea—Mycophenolic acid—psoriasis	0.000642	0.000642	CcSEcCtD
Apraclonidine—Angiopathy—Prednisone—psoriasis	0.000641	0.000641	CcSEcCtD
Apraclonidine—Conjunctivitis—Methotrexate—psoriasis	0.00064	0.00064	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.00064	0.00064	CcSEcCtD
Apraclonidine—Malaise—Betamethasone—psoriasis	0.000637	0.000637	CcSEcCtD
Apraclonidine—Malaise—Dexamethasone—psoriasis	0.000637	0.000637	CcSEcCtD
Apraclonidine—Oedema—Triamcinolone—psoriasis	0.000635	0.000635	CcSEcCtD
Apraclonidine—Syncope—Betamethasone—psoriasis	0.000634	0.000634	CcSEcCtD
Apraclonidine—Syncope—Dexamethasone—psoriasis	0.000634	0.000634	CcSEcCtD
Apraclonidine—Pain—Mycophenolate mofetil—psoriasis	0.000633	0.000633	CcSEcCtD
Apraclonidine—Constipation—Mycophenolate mofetil—psoriasis	0.000633	0.000633	CcSEcCtD
Apraclonidine—Arrhythmia—Prednisone—psoriasis	0.000631	0.000631	CcSEcCtD
Apraclonidine—Infection—Triamcinolone—psoriasis	0.000631	0.000631	CcSEcCtD
Apraclonidine—Feeling abnormal—Cyclosporine—psoriasis	0.000626	0.000626	CcSEcCtD
Apraclonidine—Insomnia—Prednisolone—psoriasis	0.000625	0.000625	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Cyclosporine—psoriasis	0.000621	0.000621	CcSEcCtD
Apraclonidine—Dizziness—Mycophenolic acid—psoriasis	0.000621	0.000621	CcSEcCtD
Apraclonidine—Paraesthesia—Prednisolone—psoriasis	0.00062	0.00062	CcSEcCtD
Apraclonidine—Mental disorder—Prednisone—psoriasis	0.000619	0.000619	CcSEcCtD
Apraclonidine—Erythema—Prednisone—psoriasis	0.000615	0.000615	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000615	0.000615	CcSEcCtD
Apraclonidine—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.00061	0.00061	CcSEcCtD
Apraclonidine—Insomnia—Hydrocortisone—psoriasis	0.00061	0.00061	CcSEcCtD
Apraclonidine—Paraesthesia—Hydrocortisone—psoriasis	0.000606	0.000606	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000606	0.000606	CcSEcCtD
Apraclonidine—Myalgia—Dexamethasone—psoriasis	0.000601	0.000601	CcSEcCtD
Apraclonidine—Myalgia—Betamethasone—psoriasis	0.000601	0.000601	CcSEcCtD
Apraclonidine—Abdominal pain—Cyclosporine—psoriasis	0.0006	0.0006	CcSEcCtD
Apraclonidine—Vomiting—Mycophenolic acid—psoriasis	0.000597	0.000597	CcSEcCtD
Apraclonidine—Discomfort—Betamethasone—psoriasis	0.000594	0.000594	CcSEcCtD
Apraclonidine—Discomfort—Dexamethasone—psoriasis	0.000594	0.000594	CcSEcCtD
Apraclonidine—Dermatitis—Mycophenolic acid—psoriasis	0.000591	0.000591	CcSEcCtD
Apraclonidine—Pain—Prednisolone—psoriasis	0.000591	0.000591	CcSEcCtD
Apraclonidine—Haemorrhage—Methotrexate—psoriasis	0.000591	0.000591	CcSEcCtD
Apraclonidine—Headache—Mycophenolic acid—psoriasis	0.000588	0.000588	CcSEcCtD
Apraclonidine—Pharyngitis—Methotrexate—psoriasis	0.000586	0.000586	CcSEcCtD
Apraclonidine—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000586	0.000586	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000583	0.000583	CcSEcCtD
Apraclonidine—Fatigue—Hydrocortisone—psoriasis	0.000582	0.000582	CcSEcCtD
Apraclonidine—Vision blurred—Prednisone—psoriasis	0.00058	0.00058	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000579	0.000579	CcSEcCtD
Apraclonidine—Pain—Hydrocortisone—psoriasis	0.000577	0.000577	CcSEcCtD
Apraclonidine—Oedema—Dexamethasone—psoriasis	0.000577	0.000577	CcSEcCtD
Apraclonidine—Oedema—Betamethasone—psoriasis	0.000577	0.000577	CcSEcCtD
Apraclonidine—Insomnia—Triamcinolone—psoriasis	0.000575	0.000575	CcSEcCtD
Apraclonidine—Infection—Dexamethasone—psoriasis	0.000573	0.000573	CcSEcCtD
Apraclonidine—Infection—Betamethasone—psoriasis	0.000573	0.000573	CcSEcCtD
Apraclonidine—Ill-defined disorder—Prednisone—psoriasis	0.000571	0.000571	CcSEcCtD
Apraclonidine—Paraesthesia—Triamcinolone—psoriasis	0.000571	0.000571	CcSEcCtD
Apraclonidine—Feeling abnormal—Prednisolone—psoriasis	0.000569	0.000569	CcSEcCtD
Apraclonidine—Visual impairment—Methotrexate—psoriasis	0.000569	0.000569	CcSEcCtD
Apraclonidine—Dyspnoea—Triamcinolone—psoriasis	0.000567	0.000567	CcSEcCtD
Apraclonidine—Nervous system disorder—Betamethasone—psoriasis	0.000565	0.000565	CcSEcCtD
Apraclonidine—Nervous system disorder—Dexamethasone—psoriasis	0.000565	0.000565	CcSEcCtD
Apraclonidine—Hypersensitivity—Cyclosporine—psoriasis	0.000559	0.000559	CcSEcCtD
Apraclonidine—Nausea—Mycophenolic acid—psoriasis	0.000558	0.000558	CcSEcCtD
Apraclonidine—Feeling abnormal—Hydrocortisone—psoriasis	0.000556	0.000556	CcSEcCtD
Apraclonidine—Malaise—Prednisone—psoriasis	0.000555	0.000555	CcSEcCtD
Apraclonidine—Eye disorder—Methotrexate—psoriasis	0.000552	0.000552	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000552	0.000552	CcSEcCtD
Apraclonidine—Syncope—Prednisone—psoriasis	0.000552	0.000552	CcSEcCtD
Apraclonidine—Fatigue—Triamcinolone—psoriasis	0.000548	0.000548	CcSEcCtD
Apraclonidine—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000546	0.000546	CcSEcCtD
Apraclonidine—Asthenia—Cyclosporine—psoriasis	0.000545	0.000545	CcSEcCtD
Apraclonidine—Pain—Triamcinolone—psoriasis	0.000543	0.000543	CcSEcCtD
Apraclonidine—Pruritus—Cyclosporine—psoriasis	0.000537	0.000537	CcSEcCtD
Apraclonidine—Angiopathy—Methotrexate—psoriasis	0.000536	0.000536	CcSEcCtD
Apraclonidine—Abdominal pain—Hydrocortisone—psoriasis	0.000533	0.000533	CcSEcCtD
Apraclonidine—Mediastinal disorder—Methotrexate—psoriasis	0.000532	0.000532	CcSEcCtD
Apraclonidine—Asthenia—Mycophenolate mofetil—psoriasis	0.000531	0.000531	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000525	0.000525	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000525	0.000525	CcSEcCtD
Apraclonidine—Pruritus—Mycophenolate mofetil—psoriasis	0.000524	0.000524	CcSEcCtD
Apraclonidine—Myalgia—Prednisone—psoriasis	0.000524	0.000524	CcSEcCtD
Apraclonidine—Feeling abnormal—Triamcinolone—psoriasis	0.000524	0.000524	CcSEcCtD
Apraclonidine—Insomnia—Dexamethasone—psoriasis	0.000521	0.000521	CcSEcCtD
Apraclonidine—Insomnia—Betamethasone—psoriasis	0.000521	0.000521	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.00052	0.00052	CcSEcCtD
Apraclonidine—Diarrhoea—Cyclosporine—psoriasis	0.00052	0.00052	CcSEcCtD
Apraclonidine—Paraesthesia—Dexamethasone—psoriasis	0.000518	0.000518	CcSEcCtD
Apraclonidine—Paraesthesia—Betamethasone—psoriasis	0.000518	0.000518	CcSEcCtD
Apraclonidine—Discomfort—Prednisone—psoriasis	0.000517	0.000517	CcSEcCtD
Apraclonidine—Mental disorder—Methotrexate—psoriasis	0.000517	0.000517	CcSEcCtD
Apraclonidine—Erythema—Methotrexate—psoriasis	0.000514	0.000514	CcSEcCtD
Apraclonidine—Hypersensitivity—Prednisolone—psoriasis	0.000509	0.000509	CcSEcCtD
Apraclonidine—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000507	0.000507	CcSEcCtD
Apraclonidine—Dysgeusia—Methotrexate—psoriasis	0.000504	0.000504	CcSEcCtD
Apraclonidine—Dizziness—Cyclosporine—psoriasis	0.000502	0.000502	CcSEcCtD
Apraclonidine—Oedema—Prednisone—psoriasis	0.000502	0.000502	CcSEcCtD
Apraclonidine—Infection—Prednisone—psoriasis	0.000499	0.000499	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000498	0.000498	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Betamethasone—psoriasis	0.000498	0.000498	CcSEcCtD
Apraclonidine—Hypersensitivity—Hydrocortisone—psoriasis	0.000497	0.000497	CcSEcCtD
Apraclonidine—Fatigue—Dexamethasone—psoriasis	0.000497	0.000497	CcSEcCtD
Apraclonidine—Fatigue—Betamethasone—psoriasis	0.000497	0.000497	CcSEcCtD
Apraclonidine—Pain—Dexamethasone—psoriasis	0.000493	0.000493	CcSEcCtD
Apraclonidine—Pain—Betamethasone—psoriasis	0.000493	0.000493	CcSEcCtD
Apraclonidine—Nervous system disorder—Prednisone—psoriasis	0.000492	0.000492	CcSEcCtD
Apraclonidine—Dizziness—Mycophenolate mofetil—psoriasis	0.00049	0.00049	CcSEcCtD
Apraclonidine—Skin disorder—Prednisone—psoriasis	0.000488	0.000488	CcSEcCtD
Apraclonidine—Vision blurred—Methotrexate—psoriasis	0.000485	0.000485	CcSEcCtD
Apraclonidine—Asthenia—Hydrocortisone—psoriasis	0.000484	0.000484	CcSEcCtD
Apraclonidine—Vomiting—Cyclosporine—psoriasis	0.000483	0.000483	CcSEcCtD
Apraclonidine—Dermatitis—Cyclosporine—psoriasis	0.000478	0.000478	CcSEcCtD
Apraclonidine—Pruritus—Hydrocortisone—psoriasis	0.000477	0.000477	CcSEcCtD
Apraclonidine—Ill-defined disorder—Methotrexate—psoriasis	0.000477	0.000477	CcSEcCtD
Apraclonidine—Headache—Cyclosporine—psoriasis	0.000476	0.000476	CcSEcCtD
Apraclonidine—Feeling abnormal—Betamethasone—psoriasis	0.000475	0.000475	CcSEcCtD
Apraclonidine—Feeling abnormal—Dexamethasone—psoriasis	0.000475	0.000475	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Betamethasone—psoriasis	0.000471	0.000471	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Dexamethasone—psoriasis	0.000471	0.000471	CcSEcCtD
Apraclonidine—Vomiting—Mycophenolate mofetil—psoriasis	0.000471	0.000471	CcSEcCtD
Apraclonidine—Hypersensitivity—Triamcinolone—psoriasis	0.000468	0.000468	CcSEcCtD
Apraclonidine—Dermatitis—Mycophenolate mofetil—psoriasis	0.000467	0.000467	CcSEcCtD
Apraclonidine—Headache—Mycophenolate mofetil—psoriasis	0.000464	0.000464	CcSEcCtD
Apraclonidine—Malaise—Methotrexate—psoriasis	0.000464	0.000464	CcSEcCtD
Apraclonidine—Diarrhoea—Hydrocortisone—psoriasis	0.000462	0.000462	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Prednisone—psoriasis	0.000457	0.000457	CcSEcCtD
Apraclonidine—Dizziness—Prednisolone—psoriasis	0.000457	0.000457	CcSEcCtD
Apraclonidine—Asthenia—Triamcinolone—psoriasis	0.000456	0.000456	CcSEcCtD
Apraclonidine—Abdominal pain—Dexamethasone—psoriasis	0.000456	0.000456	CcSEcCtD
Apraclonidine—Abdominal pain—Betamethasone—psoriasis	0.000456	0.000456	CcSEcCtD
Apraclonidine—Insomnia—Prednisone—psoriasis	0.000454	0.000454	CcSEcCtD
Apraclonidine—Nausea—Cyclosporine—psoriasis	0.000451	0.000451	CcSEcCtD
Apraclonidine—Paraesthesia—Prednisone—psoriasis	0.000451	0.000451	CcSEcCtD
Apraclonidine—Pruritus—Triamcinolone—psoriasis	0.00045	0.00045	CcSEcCtD
Apraclonidine—Dizziness—Hydrocortisone—psoriasis	0.000446	0.000446	CcSEcCtD
Apraclonidine—Nausea—Mycophenolate mofetil—psoriasis	0.00044	0.00044	CcSEcCtD
Apraclonidine—Myalgia—Methotrexate—psoriasis	0.000438	0.000438	CcSEcCtD
Apraclonidine—Chest pain—Methotrexate—psoriasis	0.000438	0.000438	CcSEcCtD
Apraclonidine—Dermatitis—Prednisolone—psoriasis	0.000435	0.000435	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000435	0.000435	CcSEcCtD
Apraclonidine—Fatigue—Prednisone—psoriasis	0.000433	0.000433	CcSEcCtD
Apraclonidine—Headache—Prednisolone—psoriasis	0.000433	0.000433	CcSEcCtD
Apraclonidine—Discomfort—Methotrexate—psoriasis	0.000432	0.000432	CcSEcCtD
Apraclonidine—Constipation—Prednisone—psoriasis	0.000429	0.000429	CcSEcCtD
Apraclonidine—Vomiting—Hydrocortisone—psoriasis	0.000429	0.000429	CcSEcCtD
Apraclonidine—Dermatitis—Hydrocortisone—psoriasis	0.000425	0.000425	CcSEcCtD
Apraclonidine—Headache—Hydrocortisone—psoriasis	0.000423	0.000423	CcSEcCtD
Apraclonidine—Dizziness—Triamcinolone—psoriasis	0.00042	0.00042	CcSEcCtD
Apraclonidine—Infection—Methotrexate—psoriasis	0.000417	0.000417	CcSEcCtD
Apraclonidine—Feeling abnormal—Prednisone—psoriasis	0.000414	0.000414	CcSEcCtD
Apraclonidine—Asthenia—Dexamethasone—psoriasis	0.000414	0.000414	CcSEcCtD
Apraclonidine—Asthenia—Betamethasone—psoriasis	0.000414	0.000414	CcSEcCtD
Apraclonidine—Nervous system disorder—Methotrexate—psoriasis	0.000412	0.000412	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Prednisone—psoriasis	0.000411	0.000411	CcSEcCtD
Apraclonidine—Nausea—Prednisolone—psoriasis	0.00041	0.00041	CcSEcCtD
Apraclonidine—Pruritus—Betamethasone—psoriasis	0.000408	0.000408	CcSEcCtD
Apraclonidine—Pruritus—Dexamethasone—psoriasis	0.000408	0.000408	CcSEcCtD
Apraclonidine—Skin disorder—Methotrexate—psoriasis	0.000408	0.000408	CcSEcCtD
Apraclonidine—Vomiting—Triamcinolone—psoriasis	0.000404	0.000404	CcSEcCtD
Apraclonidine—Nausea—Hydrocortisone—psoriasis	0.000401	0.000401	CcSEcCtD
Apraclonidine—Dermatitis—Triamcinolone—psoriasis	0.0004	0.0004	CcSEcCtD
Apraclonidine—Headache—Triamcinolone—psoriasis	0.000398	0.000398	CcSEcCtD
Apraclonidine—Abdominal pain—Prednisone—psoriasis	0.000397	0.000397	CcSEcCtD
Apraclonidine—Diarrhoea—Betamethasone—psoriasis	0.000394	0.000394	CcSEcCtD
Apraclonidine—Diarrhoea—Dexamethasone—psoriasis	0.000394	0.000394	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000382	0.000382	CcSEcCtD
Apraclonidine—Dizziness—Betamethasone—psoriasis	0.000381	0.000381	CcSEcCtD
Apraclonidine—Dizziness—Dexamethasone—psoriasis	0.000381	0.000381	CcSEcCtD
Apraclonidine—Insomnia—Methotrexate—psoriasis	0.00038	0.00038	CcSEcCtD
Apraclonidine—Nausea—Triamcinolone—psoriasis	0.000377	0.000377	CcSEcCtD
Apraclonidine—Paraesthesia—Methotrexate—psoriasis	0.000377	0.000377	CcSEcCtD
Apraclonidine—Dyspnoea—Methotrexate—psoriasis	0.000374	0.000374	CcSEcCtD
Apraclonidine—Somnolence—Methotrexate—psoriasis	0.000373	0.000373	CcSEcCtD
Apraclonidine—Hypersensitivity—Prednisone—psoriasis	0.00037	0.00037	CcSEcCtD
Apraclonidine—Vomiting—Betamethasone—psoriasis	0.000367	0.000367	CcSEcCtD
Apraclonidine—Vomiting—Dexamethasone—psoriasis	0.000367	0.000367	CcSEcCtD
Apraclonidine—Dermatitis—Betamethasone—psoriasis	0.000363	0.000363	CcSEcCtD
Apraclonidine—Dermatitis—Dexamethasone—psoriasis	0.000363	0.000363	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Methotrexate—psoriasis	0.000362	0.000362	CcSEcCtD
Apraclonidine—Fatigue—Methotrexate—psoriasis	0.000362	0.000362	CcSEcCtD
Apraclonidine—Headache—Betamethasone—psoriasis	0.000361	0.000361	CcSEcCtD
Apraclonidine—Headache—Dexamethasone—psoriasis	0.000361	0.000361	CcSEcCtD
Apraclonidine—Asthenia—Prednisone—psoriasis	0.00036	0.00036	CcSEcCtD
Apraclonidine—Pain—Methotrexate—psoriasis	0.000359	0.000359	CcSEcCtD
Apraclonidine—Pruritus—Prednisone—psoriasis	0.000355	0.000355	CcSEcCtD
Apraclonidine—Feeling abnormal—Methotrexate—psoriasis	0.000346	0.000346	CcSEcCtD
Apraclonidine—Diarrhoea—Prednisone—psoriasis	0.000344	0.000344	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Methotrexate—psoriasis	0.000343	0.000343	CcSEcCtD
Apraclonidine—Nausea—Dexamethasone—psoriasis	0.000342	0.000342	CcSEcCtD
Apraclonidine—Nausea—Betamethasone—psoriasis	0.000342	0.000342	CcSEcCtD
Apraclonidine—Dizziness—Prednisone—psoriasis	0.000332	0.000332	CcSEcCtD
Apraclonidine—Abdominal pain—Methotrexate—psoriasis	0.000332	0.000332	CcSEcCtD
Apraclonidine—Vomiting—Prednisone—psoriasis	0.000319	0.000319	CcSEcCtD
Apraclonidine—Dermatitis—Prednisone—psoriasis	0.000316	0.000316	CcSEcCtD
Apraclonidine—Headache—Prednisone—psoriasis	0.000315	0.000315	CcSEcCtD
Apraclonidine—Hypersensitivity—Methotrexate—psoriasis	0.000309	0.000309	CcSEcCtD
Apraclonidine—Asthenia—Methotrexate—psoriasis	0.000301	0.000301	CcSEcCtD
Apraclonidine—Nausea—Prednisone—psoriasis	0.000298	0.000298	CcSEcCtD
Apraclonidine—Pruritus—Methotrexate—psoriasis	0.000297	0.000297	CcSEcCtD
Apraclonidine—Diarrhoea—Methotrexate—psoriasis	0.000287	0.000287	CcSEcCtD
Apraclonidine—Dizziness—Methotrexate—psoriasis	0.000277	0.000277	CcSEcCtD
Apraclonidine—Vomiting—Methotrexate—psoriasis	0.000267	0.000267	CcSEcCtD
Apraclonidine—Dermatitis—Methotrexate—psoriasis	0.000264	0.000264	CcSEcCtD
Apraclonidine—Headache—Methotrexate—psoriasis	0.000263	0.000263	CcSEcCtD
Apraclonidine—Nausea—Methotrexate—psoriasis	0.000249	0.000249	CcSEcCtD
